JP2009528065A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009528065A5 JP2009528065A5 JP2008557419A JP2008557419A JP2009528065A5 JP 2009528065 A5 JP2009528065 A5 JP 2009528065A5 JP 2008557419 A JP2008557419 A JP 2008557419A JP 2008557419 A JP2008557419 A JP 2008557419A JP 2009528065 A5 JP2009528065 A5 JP 2009528065A5
- Authority
- JP
- Japan
- Prior art keywords
- polynucleotide
- seq
- acta
- listeria bacterium
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108091033319 polynucleotide Proteins 0.000 claims 16
- 102000040430 polynucleotide Human genes 0.000 claims 16
- 239000002157 polynucleotide Substances 0.000 claims 16
- 241000186781 Listeria Species 0.000 claims 9
- 125000000539 amino acid group Chemical group 0.000 claims 5
- 239000000427 antigen Substances 0.000 claims 5
- 102000036639 antigens Human genes 0.000 claims 5
- 108091007433 antigens Proteins 0.000 claims 5
- 108010076504 Protein Sorting Signals Proteins 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 230000001018 virulence Effects 0.000 claims 4
- 101000576802 Homo sapiens Mesothelin Proteins 0.000 claims 2
- 101001136592 Homo sapiens Prostate stem cell antigen Proteins 0.000 claims 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 230000037430 deletion Effects 0.000 claims 2
- 238000012217 deletion Methods 0.000 claims 2
- 102000050405 human PSCA Human genes 0.000 claims 2
- 229930182817 methionine Natural products 0.000 claims 2
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 claims 2
- 102000039446 nucleic acids Human genes 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 150000007523 nucleic acids Chemical class 0.000 claims 2
- 239000004474 valine Substances 0.000 claims 2
- 102000015693 Actin Depolymerizing Factors Human genes 0.000 claims 1
- 108010038798 Actin Depolymerizing Factors Proteins 0.000 claims 1
- 108091026890 Coding region Proteins 0.000 claims 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 1
- 241000186779 Listeria monocytogenes Species 0.000 claims 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 1
- 230000002238 attenuated effect Effects 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 230000001419 dependent effect Effects 0.000 claims 1
- 108020001507 fusion proteins Proteins 0.000 claims 1
- 102000037865 fusion proteins Human genes 0.000 claims 1
- 230000002779 inactivation Effects 0.000 claims 1
- 239000012678 infectious agent Substances 0.000 claims 1
- 101150046348 inlB gene Proteins 0.000 claims 1
- 230000037431 insertion Effects 0.000 claims 1
- 238000003780 insertion Methods 0.000 claims 1
- 230000010354 integration Effects 0.000 claims 1
- 230000009545 invasion Effects 0.000 claims 1
- 230000035772 mutation Effects 0.000 claims 1
- 210000001539 phagocyte Anatomy 0.000 claims 1
- 150000003904 phospholipids Chemical group 0.000 claims 1
- 239000013612 plasmid Substances 0.000 claims 1
- 101150093386 prfA gene Proteins 0.000 claims 1
- 101150027417 recU gene Proteins 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77847106P | 2006-03-01 | 2006-03-01 | |
| US60/778,471 | 2006-03-01 | ||
| US78457606P | 2006-03-21 | 2006-03-21 | |
| US60/784,576 | 2006-03-21 | ||
| US11/395,197 US7935804B2 (en) | 2006-03-01 | 2006-03-30 | Engineered Listeria and methods of use thereof |
| US11/395,197 | 2006-03-30 | ||
| US11/396,216 US20070207171A1 (en) | 2006-03-01 | 2006-03-30 | Engineered listeria and methods of use thereof |
| US11/396,216 | 2006-03-30 | ||
| PCT/US2007/005457 WO2007103225A2 (en) | 2006-03-01 | 2007-03-01 | Engineered listeria and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009528065A JP2009528065A (ja) | 2009-08-06 |
| JP2009528065A5 true JP2009528065A5 (OSRAM) | 2010-04-15 |
| JP5347135B2 JP5347135B2 (ja) | 2013-11-20 |
Family
ID=38475431
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008557419A Expired - Fee Related JP5347135B2 (ja) | 2006-03-01 | 2007-03-01 | 遺伝子工学操作されたｌｉｓｔｅｒｉａおよびその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| EP (2) | EP2860253B1 (OSRAM) |
| JP (1) | JP5347135B2 (OSRAM) |
| DK (1) | DK1991263T3 (OSRAM) |
| ES (1) | ES2532942T3 (OSRAM) |
| GB (1) | GB2451014B (OSRAM) |
| PT (1) | PT1991263E (OSRAM) |
| SI (1) | SI1991263T1 (OSRAM) |
| WO (1) | WO2007103225A2 (OSRAM) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9012141B2 (en) | 2000-03-27 | 2015-04-21 | Advaxis, Inc. | Compositions and methods comprising KLK3 of FOLH1 antigen |
| US7935804B2 (en) | 2006-03-01 | 2011-05-03 | Aduro Biotech | Engineered Listeria and methods of use thereof |
| US9017660B2 (en) | 2009-11-11 | 2015-04-28 | Advaxis, Inc. | Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors |
| DK2853269T3 (da) * | 2008-05-19 | 2019-08-05 | Advaxis Inc | Dobbelt indgivelsessystem til heterologe antigener, der omfatter en rekombinant Listeria-stamme svækket ved mutation af dal/dat og deletion af ActA, der omfatter et nukleinsyremolekyle, der koder for et listeriolysin O-prostataspecifikt antigenfusionsprotein |
| US9650639B2 (en) | 2008-05-19 | 2017-05-16 | Advaxis, Inc. | Dual delivery system for heterologous antigens |
| US10016617B2 (en) | 2009-11-11 | 2018-07-10 | The Trustees Of The University Of Pennsylvania | Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancers |
| WO2011149852A1 (en) * | 2010-05-23 | 2011-12-01 | Aduro Biotech | Methods and compositions using listeria for adjuvant treatment of cancer |
| EP2621527A4 (en) | 2010-10-01 | 2015-12-09 | Univ Pennsylvania | USE OF LISTERIA VACCINE VECTORS TO REVERSE VACCINE IMMUNITY IN PATIENTS WITH PARASITIC INFECTIONS |
| SMT201800444T1 (it) | 2010-11-17 | 2018-09-13 | Aduro Biotech Inc | Metodi e composizioni per indurre una risposta immunitaria contro egfrviii |
| CN103687611A (zh) | 2011-03-11 | 2014-03-26 | 阿德瓦希斯公司 | 基于李斯特菌属的佐剂 |
| AU2013232291B8 (en) | 2012-03-12 | 2016-07-21 | Advaxis, Inc. | Suppressor cell function inhibition following listeria vaccine treatment |
| HK1213008A1 (zh) * | 2012-11-06 | 2016-06-24 | 艾杜罗生物科技公司 | 兼性减毒细菌种类及其制备和使用方法 |
| SG10201700916SA (en) | 2012-12-27 | 2017-03-30 | Aduro Biotech Inc | Signal peptide fusion partners facilitating listerial expression of antigenic sequences and methods of preparation and use thereof |
| US10925945B2 (en) | 2014-10-13 | 2021-02-23 | Providence Health & Services-Oregon | Bacterial vaccines deficient in the 2-C-methyl-D-erythritol-4-phosphate pathway and methods of preparation and use thereof |
| CR20170507A (es) * | 2015-04-13 | 2018-02-13 | Aduro Biotech Inc | Fusiones de variante iii del receptor de factor de crecimiento epidérmico-mesotelina y métodos para usar los mismos. |
| CA2982543A1 (en) | 2015-04-13 | 2016-10-20 | Aduro Biotech, Inc. | Immunogenic fusion proteins for the treatment of cancer |
| AU2016283389B2 (en) | 2015-06-26 | 2022-09-15 | Cerus Corporation | Cryoprecipitate compositions and methods of preparation thereof |
| CA3003097A1 (en) | 2015-10-23 | 2017-04-27 | Cerus Corporation | Plasma compositions and methods of use thereof |
| CA3008641A1 (en) | 2015-12-16 | 2017-06-22 | Gritstone Oncology, Inc. | Neoantigen identification, manufacture, and use |
| ES2915410T3 (es) | 2016-06-23 | 2022-06-22 | Jiangsu Hengrui Medicine Co | Anticuerpo contra LAG-3, fragmento de unión a antígeno del mismo y aplicación farmacéutica del mismo |
| EA201991506A1 (ru) | 2016-12-23 | 2020-01-23 | Сирус Корпорейшн | Системы и способы для тестирования и скрининга с использованием связанных с соединениями субстратов |
| US11235090B2 (en) | 2017-03-03 | 2022-02-01 | Cerus Corporation | Kits and methods for preparing pathogen-inactivated platelet compositions |
| WO2019075112A1 (en) | 2017-10-10 | 2019-04-18 | Gritstone Oncology, Inc. | IDENTIFICATION OF NEO-ANTIGENS USING HOT POINTS |
| EP3714275A4 (en) | 2017-11-22 | 2021-10-27 | Gritstone bio, Inc. | REDUCTION OF JUNCTION EPITOPIC PRESENTATION FOR NEOANTIGENS |
| WO2019118760A1 (en) * | 2017-12-13 | 2019-06-20 | Inovio Pharmaceuticals, Inc. | Cancer vaccines targeting mesothelin and uses thereof |
| TWI821233B (zh) | 2017-12-29 | 2023-11-11 | 美商西勒斯股份有限公司 | 用於處理生物流體之方法、藉由該方法製備之病原體去活生物流體、及用於處理生物流體之系統 |
| MX2021015653A (es) | 2019-06-22 | 2022-04-11 | Cerus Corp | Sistemas de tratamiento de fluidos biologicos. |
| JP7645203B2 (ja) | 2019-06-28 | 2025-03-13 | シーラス コーポレイション | 生物学的流体処理デバイスを実装するためのシステム及び方法 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6551784B2 (en) | 1989-06-07 | 2003-04-22 | Affymetrix Inc | Method of comparing nucleic acid sequences |
| US5571702A (en) | 1991-03-29 | 1996-11-05 | Genentech, Inc. | Amplification method for detection of human PF4A receptors |
| IT1262895B (it) | 1992-03-02 | 1996-07-22 | Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico. | |
| IL107366A (en) | 1992-10-23 | 2003-03-12 | Chugai Pharmaceutical Co Ltd | Genes coding for megakaryocyte potentiator |
| US6379943B1 (en) | 1999-03-05 | 2002-04-30 | Merck & Co., Inc. | High-efficiency Cre/loxp based system for construction of adenovirus vectors |
| US7662396B2 (en) * | 2001-03-26 | 2010-02-16 | The Trustees Of The University Of Pennsylvania | Compositions and methods for enhancing the immunogenicity of antigens |
| WO1997003715A1 (en) | 1995-07-21 | 1997-02-06 | The General Hospital Corporation | Method and apparatus of enhancing the delivery of a pharmaceutical formulation |
| AU703769B2 (en) | 1996-01-05 | 1999-04-01 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Mesothelium antigen and methods and kits for targeting it |
| US6809184B1 (en) | 1997-12-01 | 2004-10-26 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Antibodies, including FV molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use |
| IL151942A0 (en) * | 2000-03-29 | 2003-04-10 | Univ Pennsylvania | Compositions and methods for enhancing immunogenicity of antigens |
| US6855320B2 (en) * | 2000-03-29 | 2005-02-15 | The Trustees Of The University Of Pennsylvania | Fusion of non-hemolytic, truncated form of listeriolysin O to antigens to enhance immunogenicity |
| AU2001269762C1 (en) | 2000-06-09 | 2005-12-22 | The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Pegylation of linkers improves antitumor activity and reduces toxicity of immunoconjugates |
| US7425449B2 (en) | 2002-04-30 | 2008-09-16 | The Regents Of The University Of California | Site specific Listeria integration vectors and methods for using the same |
| JP4839209B2 (ja) | 2003-02-06 | 2011-12-21 | アンザ セラピューティクス，インコーポレイテッド | 改変された自由生活微生物、ワクチン組成物、およびそれらの使用方法 |
| EP1592441B1 (en) | 2003-02-06 | 2012-04-11 | Aduro Biotech | Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the listeria, and methods of use thereof |
| US20050147621A1 (en) | 2003-10-10 | 2005-07-07 | Higgins Darren E. | Use of bacterial 5' untranslated regions for nucleic acid expression |
| EP1682173A4 (en) | 2003-10-15 | 2007-10-31 | Medimmune Inc | EPHA2 VACCINE ON LISTERIA BASE |
| US7842289B2 (en) | 2003-12-24 | 2010-11-30 | Aduro Biotech | Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof |
| CA2551644C (en) * | 2003-12-24 | 2014-03-04 | Cerus Corporation | Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of usethereof |
| US20060135457A1 (en) * | 2004-08-13 | 2006-06-22 | Yvonne Paterson | Methods for constructing antibiotic resistance free vaccines |
| ES2543079T3 (es) * | 2004-08-13 | 2015-08-14 | The Trustees Of The University Of Pennsylvania | Métodos para construir vacunas sin resistencia antibiótica |
-
2007
- 2007-03-01 GB GB0817892A patent/GB2451014B/en not_active Expired - Fee Related
- 2007-03-01 ES ES07752174.8T patent/ES2532942T3/es active Active
- 2007-03-01 EP EP14193181.6A patent/EP2860253B1/en not_active Not-in-force
- 2007-03-01 JP JP2008557419A patent/JP5347135B2/ja not_active Expired - Fee Related
- 2007-03-01 WO PCT/US2007/005457 patent/WO2007103225A2/en not_active Ceased
- 2007-03-01 EP EP07752174.8A patent/EP1991263B8/en not_active Not-in-force
- 2007-03-01 DK DK07752174T patent/DK1991263T3/en active
- 2007-03-01 PT PT07752174T patent/PT1991263E/pt unknown
- 2007-03-01 SI SI200731608T patent/SI1991263T1/sl unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009528065A5 (OSRAM) | ||
| Ridpath et al. | Delayed onset postvaccinal mucosal disease as a result of genetic recombination between genotype 1 and genotype 2 BVDV | |
| ES2255181T3 (es) | Antigeno inmunoprotector contra la gripe y su uso en vacunacion. | |
| JP2011529077A (ja) | Ｃ型肝炎の治療のための組成物および方法 | |
| JP2014504851A5 (OSRAM) | ||
| Babin et al. | Engineering of papaya mosaic virus (PapMV) nanoparticles with a CTL epitope derived from influenza NP | |
| CN1251042A (zh) | 广泛反应性的dr限制性表位的鉴定 | |
| JP2017513502A5 (OSRAM) | ||
| JP2020520662A5 (OSRAM) | ||
| CN112063592A (zh) | 非洲猪瘟多基因联合缺失减毒株的构建及作为疫苗的应用 | |
| JP2005509420A5 (OSRAM) | ||
| JP2012516140A5 (OSRAM) | ||
| JP2007537722A (ja) | 癌胎児性抗原融合タンパク質及びその使用 | |
| JP2003533232A5 (OSRAM) | ||
| JP2008545393A5 (OSRAM) | ||
| JP6313215B2 (ja) | 組み換え酵母を用いた、定義された抗原に対する防御的体液性免疫応答の生成による予防接種 | |
| CN100471957C (zh) | 用于免疫治疗的腺病毒载体 | |
| JP6213969B2 (ja) | 免疫原性ポリペプチド表層発現ビフィズス菌 | |
| EP2483409B1 (en) | LACTOBACILLUS glyceraldehyde-3-phosphate dehydrogenase PROMOTERS AND USES THEREOF | |
| CN117535322A (zh) | 具有异源抗原的活的减毒黄病毒 | |
| CN1471580A (zh) | 含有外源性内表位的病毒颗粒 | |
| US20160324954A1 (en) | Immunogenic compositions for inhibiting hepatitis d virus | |
| JP2007518405A5 (OSRAM) | ||
| WO2004096288A2 (es) | Método para la obtencion de minicírculos replicativos de adn para transferencia génica o como inmunomoduladores. | |
| CN101406698B (zh) | 展示狂犬病病毒保护性抗原的犬ⅱ型腺病毒活载体重组疫苗 |